Inland Northwest Health Services

Recent papers from Inland Northwest Health Services

1. Interleukin-6 Inhibition with Ziltivekimab for Atherosclerotic DiseaseNew England Journal of Medicine · 2026
2. Changes in Metabolic and Blood Pressure Outcomes With Semaglutide Across Chronic Kidney Disease Stages: A Post Hoc Analysis of the FLOW TrialDiabetes Obesity and Metabolism · 2026
3. High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide studyNephrology Dialysis Transplantation · 2026
4. Effect of a Mentored Virtual Research Fellowship on Research Competencies and Activities of NursesThe Journal of Continuing Education in Nursing · 2026
5. Prerenalism—A Gap That Costs Lives, Hearts, and KidneysJAMA Cardiology · 2025
6. Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trialNature Medicine · 2026
7. Belimumab with rituximab for the treatment of primary membranous nephropathyKidney International Reports · 2026
8. Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysisEuropean Heart Journal · 2026
9. Design and Baseline Characteristics of CONCORD, a Trial of Novel Therapies for Depression in CKDKidney International Reports · 2026
10. SGLT2 inhibition modulates metabolic, vascular, and inflammatory molecular markers in the kidney in youth with type 1 diabetesScience Translational Medicine · 2026
11. Aldosterone synthase inhibition for treatment of people with chronic kidney diseaseClinical Kidney Journal · 2026
12. Nephrology in the Paradigm of Cardiovascular-Kidney-Metabolic HealthClinical Journal of the American Society of Nephrology · 2026
13. Gaps, Barriers, and Facilitators to Implementing Comprehensive Medication Management in Cardiovascular‐Kidney‐Metabolic Care: A Qualitative StudyJACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · 2026
14. Real-Time Continuous Glucose Monitoring Among People With Type 2 Diabetes and End-Stage Kidney Failure Undergoing Maintenance Hemodialysis: A Randomized Clinical TrialDiabetes Care · 2026
15. Major Adverse Kidney Events in the American Indian or Alaska Native Population with DiabetesClinical Journal of the American Society of Nephrology · 2026
16. A Framework for Risk-Based Implementation of Combination Therapy in CKDClinical Journal of the American Society of Nephrology · 2026
17. Effectiveness of Foslevodopa/Foscarbidopa in Subgroups of Patients Earlier within Advanced Parkinson’s Disease in an Interim Dataset of ROSSINI (P3-17.005)Neurology · 2026
18. Foslevodopa/Foscarbidopa Improves Pain in People With Advanced Parkinson’s Disease Who Have Uncontrolled Motor Fluctuations: Interim Results From the Real-World ROSSINI Study (P3-17.006)Neurology · 2026
19. Efficacy and safety of finerenone in patients with chronic kidney disease: an individual participant data pooled analysis (INFINITY)The Lancet · 2026
20. Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE TrialDiabetes Care · 2026